Avadel Pharmaceuticals plc Ordinary Share (AVDL) is a publicly traded Healthcare sector company. As of May 20, 2026, AVDL trades at $21.39 with a market cap of $2.12B and a P/E ratio of -10.70. AVDL moved +0.00% today. Year to date, AVDL is +41.07%; over the trailing twelve months it is +140.44%. Its 52-week range spans $6.38 to $23.57. Analyst consensus is buy with an average price target of $21.25. Rallies surfaces AVDL's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Avadel Pharmaceuticals plc Ordinary Share (AVDL) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. AVDL moved +0.00% today. Analyst consensus is buy.
| Metric | Value |
|---|---|
| Price | $21.39 |
| Market Cap | $2.12B |
| P/E Ratio | -10.70 |
| EPS | $-2.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $23.57 |
| 52-Week Low | $6.38 |
| Volume | 200 |
| Avg Volume | 0 |
| Revenue (TTM) | $27.96M |
| Net Income | $-160.28M |
| Gross Margin | 96.97% |
14 analysts cover AVDL: 0 strong buy, 8 buy, 6 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $21.25.